Many planning models pair an oral precursor for daily baseline support with periodic injectable NAD+ phases
TB500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decrease inflammation [1] [2] [3]
Its not proven to cause cancer, but the risk isnt worth it when you dont know whats going on at the cellular level
Disclaimer: This product is not intended for human or animal use, diagnosis, or therapeutic applications.
Clinical studies show 250-300 mcg daily provides effective tissue repair with minimal side effects
You don't need a PhD in fungal microbiology to interpret it: oh, level 5, that's probably not good